Apogee Therapeutics, Inc.

APGE

As of the close on Sep 2, 2026

Price

—

No recent closing price

Market cap

—

No recent closing price

P/E (diluted TTM)

—

No recent closing price

EPS (TTM)

—

The fourth quarter's per-share figure could not be confirmed from the annual report

Dividend yield

—

No recent closing price

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Apogee Therapeutics, Inc. Makes Money

No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 3 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 24, 2026.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Unusually large insider trades

Each trade is compared with the other insider trades of the same kind in the same security among Apogee Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.

2026-06-22 · HENDERSON MICHAEL THOMAS: Larger than 126 of the 127 other insider sales of Common Stock on file. SEC filing
2026-06-22 · Dambkowski Carl: Larger than 122 of the 127 other insider sales of Common Stock on file. SEC filing
2026-05-13 · HENDERSON MICHAEL THOMAS: Larger than 120 of the 127 other insider sales of Common Stock on file. SEC filing
2026-04-08 · HENDERSON MICHAEL THOMAS: Larger than 119 of the 127 other insider sales of Common Stock on file. SEC filing
2026-01-22 · Harwin Peter Evan: Larger than all 127 other insider sales of Common Stock on file. SEC filing
2026-01-07 · Dambkowski Carl: Larger than 116 of the 127 other insider sales of Common Stock on file. SEC filing
2025-12-04 · HENDERSON MICHAEL THOMAS: Larger than 125 of the 127 other insider sales of Common Stock on file. SEC filing
2025-11-13 · HENDERSON MICHAEL THOMAS: Larger than 115 of the 127 other insider sales of Common Stock on file. SEC filing
2025-02-05 · HENDERSON MICHAEL THOMAS: Larger than 117 of the 127 other insider sales of Common Stock on file. SEC filing
2024-10-02 · HENDERSON MICHAEL THOMAS: Larger than 123 of the 127 other insider sales of Common Stock on file. SEC filing
2024-09-04 · HENDERSON MICHAEL THOMAS: Larger than 121 of the 127 other insider sales of Common Stock on file. SEC filing
2024-08-07 · HENDERSON MICHAEL THOMAS: Larger than 124 of the 127 other insider sales of Common Stock on file. SEC filing
2024-07-05 · HENDERSON MICHAEL THOMAS: Larger than 117 of the 127 other insider sales of Common Stock on file. SEC filing

Independent insiders buying near the same time

2023-07-13–2023-07-13: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )

Purchases & sales (open market or private)

		Security	Code		Price	Filing
2026-06-22	Dambkowski Carl · Chief Medical Officer	Common Stock	S — Open market or private sale	−26,400	132.60	SEC filing
2026-06-22	HENDERSON MICHAEL THOMAS · Chief Executive Officer	Common Stock	S — Open market or private sale	−80,000	132.54	SEC filing
2026-06-10	HENDERSON MICHAEL THOMAS · Chief Executive Officer	Common Stock	S — Open market or private sale	−6,770	82.21	SEC filing
2026-06-10	HENDERSON MICHAEL THOMAS · Chief Executive Officer	Common Stock	S — Open market or private sale	−2,305	86.27	SEC filing
2026-06-10	HENDERSON MICHAEL THOMAS · Chief Executive Officer	Common Stock	S — Open market or private sale	−7,654	82.78	SEC filing
2026-06-10	HENDERSON MICHAEL THOMAS · Chief Executive Officer	Common Stock	S — Open market or private sale	−614	86.89	SEC filing
2026-06-10	HENDERSON MICHAEL THOMAS · Chief Executive Officer	Common Stock	S — Open market or private sale	−1,080	84.18	SEC filing
2026-06-10	HENDERSON MICHAEL THOMAS · Chief Executive Officer	Common Stock	S — Open market or private sale	−1,577	85.19	SEC filing

Showing 8 of 17 rows

Grants, exercises, tax & gifts

		Security	Code		Filing
2026-06-09	Bollinger Lisa · Director	Stock Option (Right to Buy)	A — Grant, award, or other acquisition	+7,657	SEC filing
2026-06-09	JONES WILLIAM A JR · Director	Stock Option (Right to Buy)	A — Grant, award, or other acquisition	+7,657	SEC filing
2026-06-09	Shah Nimish P · Director	Stock Option (Right to Buy)	A — Grant, award, or other acquisition	+7,657	SEC filing
2026-06-09	Fairmount Funds Management LLC · Director	Stock Option (Right to Buy)	A — Grant, award, or other acquisition	+7,657	SEC filing
2026-06-09	Fox Jennifer A. · Director	Stock Option (Right to Buy)	A — Grant, award, or other acquisition	+7,657	SEC filing
2026-06-09	McKenna Mark C. · Director	Stock Option (Right to Buy)	A — Grant, award, or other acquisition	+7,657	SEC filing
2026-06-03	Dambkowski Carl · Chief Medical Officer	Stock Option (Right to Buy)	M — Exercise or conversion of derivative security	−4,125	SEC filing
2026-06-03	Dambkowski Carl · Chief Medical Officer	Common Stock	M — Exercise or conversion of derivative security	+4,125	SEC filing

Showing 8 of 20 rows

Other activity

		Security	Code		Filing
2024-03-28	Harwin Peter Evan · Director	Common Stock	J — Other acquisition or disposition	−55,913	SEC filing
2024-03-28	Harwin Peter Evan · Director	Non-Voting Common Stock	J — Other acquisition or disposition	+221,426	SEC filing
2024-03-28	Harwin Peter Evan · Director	Common Stock	J — Other acquisition or disposition	+55,913	SEC filing
2024-03-28	Harwin Peter Evan · Director	Non-Voting Common Stock	J — Other acquisition or disposition	−221,426	SEC filing
2024-01-29	Harwin Peter Evan · Director	Common Stock	J — Other acquisition or disposition	−892,529	SEC filing
2024-01-29	Harwin Peter Evan · Director	Common Stock	J — Other acquisition or disposition	+51,166	SEC filing

Showing 6 of 6 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.